HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thorne Enters Consumer Market With Sports Nutrition Supplements

This article was originally published in The Tan Sheet

Executive Summary

Thorne Research markets supplements through health care practitioners exclusively, and previously has not offered sports nutrition products, but the firm puts the same emphasis on ingredient purity and quality manufacturing in the supplements its Thorne Performance business is selling online.

You may also be interested in...



Protein, Migrating Ingredients Help Sports Category Build Muscle

Increased consumer demand for protein and the migration of popular ingredients from adjacent categories are spurring growth in sports nutrition. Protein helped drive up sales double digits for powders and formulas and the overall category grew 46% from $17.6 billion in 2006 to $25.7 billion in 2011.

People In Brief

Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.

FDA Details “Quality Agreements” For Marketers, Contract Manufacturers

The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS124963

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel